Patent · US Active

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

US9617203B2 · kind B2 · utility

1Cited by

3References

12Claims

0Family size

Assignee

VANDA PHARMACEUTICALS INC. · US

Inventors

Marlene Michelle Dressman · Germantown, US
Deepak Phadke · Olathe, US

Key dates

Filing date	Nov 10, 2015
Grant date	Apr 11, 2017
Priority date	—
Expiry date	Nov 10, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.